Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carroll, Camille B
ADOPTION, NCT04990284 / 2020-002754-24: eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.	Active, not recruiting	4	106	Europe	Opicapone, BIA 9-1067, L-DOPA/DDCI, Levodopa	Bial - Portela C S.A., Bial - Portela & Ca, S.A.	Parkinson Disease	06/23	06/23
CHIEF PD, NCT04226248: CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)	Active, not recruiting	3	600	Europe	Rivastigmine Transdermal System, Placebo Transdermal System	University of Bristol, Royal United Hospitals Bath NHS Foundation Trust	Parkinson Disease	05/24	02/25
NCT05544305: Digitised Home Based Care for Parkinson's Disease	Not yet recruiting	N/A	120	Europe	Digital Home Based Care pathway	University of Plymouth	Parkinson Disease, Parkinson	06/25	06/25